Evvy

We’re so honored to be included on Fast Co’s “World Changing Ideas” list — in not one but three categories! 🙌 → Wellness → Health → "On the Rise" — for companies less than 4 years old 🔑 Vaginal health is not niche — it lives at the center of day-to-day physical, emotional, and sexual wellbeing for so many people. So we couldn’t be more proud to see our work equally honored alongside so many other innovative companies in areas like climate change, health & wellness, technology, and more. 💙 https://lnkd.in/en9BayE3 #fcworldchangingideas #fastcompany

Evvy is again an official The Webby Awards Nominee! This year, we're nominated in Social - Public Service & Activism for our campaign, "100 Effed Facts About the Gender Health Gap".
🙌 ⚫ Spanning everything from cancer to menopause to vaginal health and beyond, "100 Effed Facts About the Gender Health Gap" is one of the most comprehensive compilations of gender health gap facts ever created. Designed with huge graphic holes — literal gaps — on every asset, the campaign instills a sense of loss, shock, and anger, plus the motivation to fix it. This recognition is meaningful not just for our team, but for the broader mission we’re working toward: creating a world in which women and people with vaginas receive the research, care, and answers they deserve.
 If you have a minute and want to support our work on closing the gender health gap, we'd love your vote: https://lnkd.in/etaVXAtJ Eli Block Annick Saralegui Priyanka Jain Pita Navarro

We're excited to share Amboy Street Ventures' latest $360B Ghost Market Report, highlighting overlooked opportunities in women's health, including vaginal microbiome care. The vaginal microbiome care market alone represents a massive $5B opportunity, demonstrating both significant unmet needs and immense potential for innovation and impact. We're proud to see Evvy featured as a leading innovator in this rapidly growing space, committed to pioneering personalized vaginal health insights. Check out the full report to learn more about the future of women's health and why investing in the vaginal microbiome is crucial: https://lnkd.in/eYrwH4WE #WomensHealth #VaginalMicrobiome #FemTech #HealthInnovation

NEW: dedicated Fertility Insights with every Evvy test 💡✨ Groundbreaking research suggests that the vaginal microbiome plays a role in fertility—impacting everything from implantation to outcomes in IVF and IUI. Yet this information has never been widely accessible in fertility care… until now. 🔑 Starting today, all Evvy test results will include dedicated Fertility Insights, measuring four Microbiome Markers associated with fertility: ✔ Protective Score– The percent of protective bacteria. Research associates higher levels with positive fertility outcomes.¹ ✔ Microbiome Diversity Score– How many different kinds of bacteria you have — research suggests fewer
is better. ✔ Fertility Disruptors– Checks for five bacteria: Fannyhassae, Gardnerella, Prevotella, Sneathia, and Ureaplasma. ✔ STI Screening (*add-on only) – Checks for 4 STIs: chlamydia, gonorrhea, Mycoplasma genitalium, and trich. With these insights, Evvy is bridging the gap between the latest research and real-world fertility care. 🔬 Learn more about our vaginal microbiome test and fertility insights at evvy.com/fertility Launch story: https://lnkd.in/ggMfkiqN —— 🔬 Explore the research behind Fertility Insights: 1. Protective Score: Väinämö 2023, Skafte-Holm 2021, Amato 2019

 2. Microbiome Diversity Score: Chopra 2024, Kong 2020

 3. Fertility Disruptors: Chopra 2024, George 2024, Väinämö 2023, Lledo 2022, Ma 2021, Ravel 2021, Gao 2020, Kong 2020, Zhao 2020, Graspeuntner 2018

 4. STI Status: Yu 2023, Hashemi 2022, Chemaitelly 2020, Mania-Pramanik 2012

Excited to see our portfolio company, Evvy, continue to push the boundaries of women’s health with the launch of new fertility insights as part of their vaginal microbiome test. The new capabilities provide information on and address the connection between vaginal microbiome health and fertility outcomes, an area where research has shown significant correlations.    “For too long, fertility has been treated like a black box — leaving millions of people searching for answers with no clear path forward,” said Priyanka Jain, co-founder and CEO of Evvy. “By expanding our Vaginal Microbiome Test to include fertility insights, we’re giving people the power to take control of their reproductive health with comprehensive testing and data-driven, personalized care.” https://lnkd.in/ggMfkiqN

🔬 Evvy, the company focusing on closing the gender health gap through vaginal microbiome biomarkers, has expanded its flagship Vaginal Microbiome Test to include fertility insights. The new capabilities provide information on how the vaginal microbiome affects reproductive health. The update addresses the connection between vaginal microbiome health and fertility outcomes, an area where research has shown significant correlations. According to the company, one-third of all infertility cases are diagnosed as “unexplained,” and vaginal microbial imbalances have been linked to infertility, recurrent pregnancy loss, and preterm birth. 🤰 💬 “For too long, fertility has been treated like a black box — leaving millions of people searching for answers with no clear path forward. By expanding our Vaginal Microbiome Test to include fertility insights, we’re giving people the power to take control of their reproductive health with comprehensive testing and data-driven, personalized care.” Priyanka Jain, Co-founder & CEO of Evvy #femtech #womenshealth #womenshealthinnovaition #vaginalhealth #pelvichealth #fertility #reproductivehealth #launch #athometesting #diagnostics

Evvy is heading to Indian Wells this week for #pcrs2025! You can find us at Booth #309 during the exhibition — stop by for some Evvy swag, giveaways, and a chance to connect with our Chief Medical Officer, Kate McLean MD, MPH, FACOG, CEO Priyanka Jain, Chief Science Officer, Pita Navarro, and Geena Shah. We are excited to bring our vaginal microbiome expertise to PCRS amidst the growing research on the relationship between the vaginal microbiome and fertility outcomes. We’ll be sharing more about our validated vaginal microbiome test and the groundbreaking research we are doing to leverage our platform to improve fertility outcomes. We’d love to meet with anyone at PCRS interested in the vaginal microbiome — send us a message if you’ll be there and want to catch up or join our provider community at evvy.com/provider!

I'm pleased to announce the addition of David Lyttle, Ph.D., Senior Bioinformatics Scientist, Evvy, to the speaking faculty for the 10th Annual Translational Microbiome Conference (https://lnkd.in/dF9GD4m) on April 10-11, 2025 in Boston. In his presentation, Dr. Lyttle will provide insights from a large-scale study of microbial taxa and biochemical pathways. Vaginitis affects up to 30% of women globally and is a leading cause of gynecological visits, with vaginal odor being the most frequently reported and distressing symptom. Despite its prevalence, the microbial and biochemical mechanisms driving odor remain poorly understood, limiting therapeutic advances. Evvy's latest research analyzed patient-reported data and shotgun metagenomic sequencing from 6,585 non-menopausal individuals, identifying seven bacterial taxa linked to odor severity. We also uncovered a significant association between the putrescine pathway and severe odor cases. These findings pave the way for translating metagenomic insights into clinical tools for precision diagnostics and targeted treatments in vaginal health. Join us at this year's event, where our speakers from both academia and industry will be sharing cutting-edge microbiome research. Join our mailing list: https://lnkd.in/gHzWmjvC Register now: https://lnkd.in/gH7ybuij #microbiome #microbiomeresearch Mollie Roth Pita Navarro

🚀 Big news: Evvy has been named to the 2025 Digital Health 100 by Digital Health New York! We're building the future of vaginal healthcare—because women’s health shouldn’t be a medical mystery. By unlocking the power of the vaginal microbiome, we’re pioneering precision medicine for women and people with vaginas, closing the gender health gap one breakthrough at a time. This recognition is proof that the world is finally paying attention. To every Evvy user, researcher, clinician, investor, and advocate who believes in better: Thank you for being part of this movement. 💜 Check out the full #DH100 list and the latest insights in the 2025 New York Healthcare Innovation Report: https://lnkd.in/gcUA3J7Q #DigitalHealth #Evvy #DH100 #WomenDeserveBetter #GenderHealthGap

Evvy is heading will be at #IHSNY25! You can find us at Booth #1618 during the exhibition. Stop by for some Evvy swag, giveaways, and a chance to connect with our CEO Priyanka Jain, Chief Science Officer Pita Navarro, Lindsay King, MS, and Geena Shah! We are excited to bring our vaginal microbiome expertise to Integrative Healthcare Symposium for the first time to share more about our innovative vaginal healthcare platform, powered by our state-of-the-art testing. Our platform is built to support both patients and providers in managing recurrent vaginal infections, menopause, fertility, and preventative care. We’d love to meet with anyone at IHS interested in the vaginal microbiome. Use this link to get a FREE ticket to the exhibition, on Evvy: https://lnkd.in/ePQqk9Vv You can also join our provider community at evvy.com/provider